| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |